FAAH (Fatty Acid Amide Hydrolase) Gene

Key regulator of endocannabinoid signaling and pain modulation

Gene Information Card

Symbol FAAH
Full Name Fatty Acid Amide Hydrolase
Gene Type Protein coding
Chromosomal Location 1p33
NCBI Gene ID 2166 ncbi.nlm.nih.gov/gene/2166
Ensembl ID ENSG00000117480
UniProt ID O00519
OMIM ID 602935
HGNC ID 3554
Aliases FAAH1, PSAB, FAAH-1

Description

The FAAH gene encodes fatty acid amide hydrolase, an integral membrane enzyme that hydrolyzes bioactive fatty acid amides, including the endocannabinoid anandamide. It plays a critical role in modulating pain, inflammation, anxiety, and memory. Genetic variants in FAAH are associated with altered endocannabinoid signaling and various neurological and psychiatric disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Anxiety disorders Reduced FAAH activity increases anandamide levels, modulating anxiety-related circuits ClinVar, OMIM
Chronic pain FAAH polymorphisms affect pain sensitivity and response to analgesics ClinVar, NCBI
Substance use disorder FAAH variants influence reward pathways and addiction risk OMIM, NCBI
Obesity FAAH expression in adipose tissue correlates with metabolic regulation NCBI, UniProt

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 High
Liver 8.3 Medium
Kidney 6.1 Medium
Small intestine 4.7 Low
Adipose tissue 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.2 High expression
SH-SY5Y 9.8 Neuronal model
HepG2 7.4 Liver model
Caco-2 5.1 Intestinal model
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.385C>A (p.Pro129Thr) Missense 0.05 Reduced enzyme activity, associated with anxiety
c.1361A>G (p.Gln454Arg) Missense 0.02 Altered substrate specificity
c.973C>T (p.Arg325Cys) Missense 0.01 Decreased catalytic efficiency
Mutation functional classification

Loss of Function (LOF)

p.Pro129Thr reduces FAAH activity, increasing anandamide levels.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported.

Dominant Negative (DN)

Not described for FAAH.

Pathways

Endocannabinoid signaling (Reactome R-HSA-373753)
Fatty acid metabolism (KEGG hsa00071)

Protein Summary

FAAH is a 579-amino acid integral membrane protein with a single transmembrane domain. It belongs to the amidase signature family and catalyzes the hydrolysis of anandamide and other bioactive amides. The enzyme is expressed in brain, liver, and other tissues, and its activity regulates endocannabinoid tone. Structural studies reveal a dimeric organization with a catalytic serine-lysine dyad.

Related Products

Product name Cat.No. Species Gene ID
FAAH Knockout HEK293 Cell Line EDJ-KQ2275 Human 2166 Details Get a Quote
FAAH2 Knockout HEK293 Cell Line EDJ-KQ13349 Human 158584 Details Get a Quote
FAAH Knockout A-549 Cell Line EDJ-KQ21290 Human 2166 Details Get a Quote
FAAH Knockout HCT 116 Cell Line EDJ-KQ22622 Human 2166 Details Get a Quote
FAAH2 Knockout HeLa Cell Line EDJ-KQ41598 Human 158584 Details Get a Quote
FAAH2 Knockout HCT 116 Cell Line EDJ-KQ42830 Human 158584 Details Get a Quote
Faah Knockout MC-38 Cell Line EDJ-KZ227 Mouse 2166 Details Get a Quote
FAAH Knockout HeLa Cell Line EDJ-KQ53194 Human 2166 Details Get a Quote
FAAH2 Knockout A-549 Cell Line EDJ-KQ67271 Human 158584 Details Get a Quote
Displaying Records 1 To 9 Of 9 Records
Contact Us
*
*
*
*
How did you hear about us: